
Guided Patient
Access
Since January 1, 2026, Early and Equitable Fast Access programs have been introduced in Belgium.
The initiative aims to provide patients with unmet medical needs quicker access to innovative treatments before or immediately after marketing authorisation. Our dedicated team helps in navigating these pathways to connect patients with life-changing therapies.
Compasionate Use Program
We specialize in designing and implementing compassionate use and medical need programs, compliant with the requirements of the competent authorities.We are fully engaged with the Early & Fast Access programs, overseen by the CATT/CAIT to bring transformative treatments faster to patients in need.



Trusted by healtcare leaders Worldwide.
Comprehensive Access Solutions
We facilitate a range of early access mechanisms tailored to bring innovation earlier to patients in Belgium.
Named Patient Program
Facilitating access for individual patients and physicians to medicines that are approved in other countries but not yet in Belgium.
Compassionate Use & Medical Need Program
We specialise in designing and implementing compassionate use and medical need programs, compliant with the requirements of the regulatory authorities.
This allows rapid and controlled access to innovative therapies prior to reimbursement.
Early & Fast Access Program
We are fully engaged with the Early & Fast Access programs, overseen by the CATT/CAIT to bring transformative treatments faster to patients in need, while generating real-world medical and safety data.
120+
SUCCESFUL
SUBMISSIONS
Why Axes health ?
Empowering healthcare innovation through expert navigation.
25+
YEARS EXPERIENCE
Expert knowledge of the Belgian healthcare landscape and regulatory framework.
100%
Executional Excellence
+25 yrs
Experience
120+
Successful Submissions
3 Countries
BeNeLux Client Partnerships

